Literature DB >> 10736121

Sexual Assault Nurse Examiner programs in the United States.

A C Ciancone1, C Wilson, R Collette, L W Gerson.   

Abstract

STUDY
OBJECTIVE: We sought to provide a descriptive study of the Sexual Assault Nurse Examiner (SANE) programs and their characteristics in the United States.
METHODS: A confidential survey addressing patient and staff demographics, administration attributes, examination procedures, and medical and legal issues was mailed to SANE programs in the United States.
RESULTS: Sixty-one (66%) of 92 programs responded. More than half of the programs (32/58 [55%]) had been in operation for less than 5 years. Thirty (52%) of the 58 programs performed the initial sexual assault examination in hospital emergency departments. Written consent (57/59 [97%]) was obtained for the initial examination, and most (51/59 [86%]) programs used preprepared commercial sexual assault kits. Program directors were predominately registered nurses. All but one program mandated specific training requirements for their staff, with a median requirement of 80 hours. Procedures used for initial examinations varied; most offered pregnancy testing (56/58 [97%]), pregnancy prophylaxis (57/59 [97%]), and sexually transmitted disease (STD) prophylaxis (53/59 [90%]). HIV testing was not offered in 32 (54%) of 59 programs. Almost all programs used Wood's lamp (51/59 [86%]), colposcopes (42/59 [71%]), and photographs (46/59 [78%]) for documentation. Median time required per patient for initial examination and evidence collection was 3 hours (range, 1 to 8 hours). Follow-up is consistently offered to the survivor. Most programs (45/61 [74%]) could report the number of survivors treated, but few could provide information on survivor medical follow-up or the number of prosecutions by survivors and their outcomes.
CONCLUSION: This survey provided an overview of SANE programs. SANE programs are similar across the country with regard to staffing, training, STD and pregnancy prophylaxis, and documentation techniques. They are inconsistent in the use of STD cultures, HIV testing, and alcohol and drug screening. SANE programs were unable to provide data regarding survivor follow-up and legal outcomes. This information is essential to evaluate the programs' effectiveness and to improve performance. The need for better outcome data should be addressed to define success or failure of SANE programs.

Entities:  

Mesh:

Year:  2000        PMID: 10736121     DOI: 10.1016/s0196-0644(00)70053-9

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

1.  Substance use among women receiving post-rape medical care, associated post-assault concerns and current substance abuse: results from a national telephone household probability sample.

Authors:  Jenna L McCauley; Dean G Kilpatrick; Kate Walsh; Heidi S Resnick
Journal:  Addict Behav       Date:  2012-12-13       Impact factor: 3.913

2.  Nonoccupational postexposure HIV prophylaxis in sexual assault programs: a survey of SANE and FNE program coordinators.

Authors:  Jessica E Draughon; Jocelyn C Anderson; Bryan R Hansen; Daniel J Sheridan
Journal:  J Assoc Nurses AIDS Care       Date:  2013-10-05       Impact factor: 1.354

3.  Rural Availability of Sexual Assault Nurse Examiners (SANEs).

Authors:  Elizabeth Thiede; Sheridan Miyamoto
Journal:  J Rural Health       Date:  2020-12-06       Impact factor: 5.667

4.  The identification and treatment of mental health and substance misuse problems in sexual assault services: A systematic review.

Authors:  Theodora Stefanidou; Elizabeth Hughes; Katherine Kester; Amanda Edmondson; Rabiya Majeed-Ariss; Christine Smith; Steven Ariss; Charlie Brooker; Gail Gilchrist; Sarah Kendal; Mike Lucock; Fay Maxted; Concetta Perot; Rebekah Shallcross; Kylee Trevillion; Brynmor Lloyd-Evans
Journal:  PLoS One       Date:  2020-04-10       Impact factor: 3.240

5.  Sexual assault training in emergency medicine residencies: a survey of program directors.

Authors:  Margaret K Sande; Kerry B Broderick; Maria E Moreira; Brooke Bender; Emily Hopkins; Jennie A Buchanan
Journal:  West J Emerg Med       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.